BIOXYNE LIMITED - Announcements

Market Cap $14.32M Add to my watchlist

Consumer Defensive Household & Personal Products

Bioxyne Limited is an Australia-based health and wellness products company. Its activity... Bioxyne Limited is an Australia-based health and wellness products company. Its activity is the development, manufacture and distribution of nutritional health and wellness supplements through indirect wholesale and direct sales channels in the health and wellness sector. It is engaged in the consumer dietary supplements and functional foods markets through its probiotic, Lactobacillus fermentum VRI-003 (PCC). The Company has developed a range of functional food and beauty products containing ingredients sourced primarily from New Zealand, through its direct sales business trading as Bioxyne International. It has an interest in Breathe Life Sciences (BLS). It has operations across Australia, the United Kingdom, Japan, Europe and Southeast Asia with a health and wellness product portfolio, including health supplements, skincare, probiotics, cannabis-derived raw materials, starting materials, active pharmaceutical ingredients, cannabinoid-based therapies and telemedicine technology.More

Announcements

Filter Results

All Price Sensitive Only

BXN	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	30/04/24	985.45KB	Share
BXN	Cleansing Notice		22/04/24	675.74KB	Share
BXN	Application for quotation of securities - BXN		22/04/24	15.39KB	Share
BXN	Proposed issue of securities - BXN		18/04/24	15.15KB	Share
BXN	Bioxyne Receives Firm Commitments to Raise $1.45 Million		18/04/24	702.1KB	Share
BXN	Bioxyne to Host Webinar on 28 March 2024		25/03/24	667.26KB	Share
BXN	Investor Presentation		25/03/24	4.86MB	Share
BXN	Notification regarding unquoted securities - BXN		22/03/24	15.56KB	Share
BXN	Notification of cessation of securities - BXN		22/03/24	12.69KB	Share
BXN	Half Yearly Report and Accounts	PRICE SENSITIVE	29/02/24	2.39MB	Share
BXN	BXN Awarded GMP Manufacturing License for Medical Cannabis	PRICE SENSITIVE	05/02/24	762.42KB	Share
BXN	Quarterly Report Listing Rule 4.7C.3		05/02/24	661.24KB	Share
BXN	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	29/01/24	965.25KB	Share
BXN	Final Director's Interest Notice		17/11/23	141.7KB	Share
BXN	Retirement of Director	PRICE SENSITIVE	17/11/23	564.48KB	Share
BXN	Results of Meeting		17/11/23	586.31KB	Share
BXN	Annual General Meeting Presentation		17/11/23	7.69MB	Share
BXN	Change in substantial holding		06/11/23	156.14KB	Share
BXN	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	31/10/23	988.5KB	Share
BXN	BLS Builds Medicinal Business In Australia		19/10/23	614.62KB	Share
BXN	Letter to Shareholders re Annual General Meeting Notice		18/10/23	608.01KB	Share
BXN	Notice of Annual General Meeting/Proxy Form		18/10/23	406.33KB	Share
BXN	Change of Director's Interest Notice		17/10/23	237.76KB	Share
BXN	Change of Director's Interest Notice		09/10/23	170.73KB	Share
BXN	AGM Date 2023 and Closing Date for Director Nominations		05/10/23	537.66KB	Share
BXN	Annual Report to shareholders		29/09/23	1.74MB	Share
BXN	Appendix 4G and Corporate Governance Statement		29/09/23	669.01KB	Share
BXN	Preliminary Final Report	PRICE SENSITIVE	31/08/23	603.85KB	Share
BXN	Bioxyne Signs Joint Venture with CanXChange		15/08/23	586.37KB	Share
BXN	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	31/07/23	989.05KB	Share
BXN	BLS Extends Amazon Footprint into US and Japan	PRICE SENSITIVE	17/07/23	632.66KB	Share
BXN	Bioxyne Launches BLS Clinics - Online Healthcare		13/06/23	628.43KB	Share
BXN	Becoming a substantial holder		08/06/23	214.36KB	Share
BXN	Becoming a substantial holder		31/05/23	1.22MB	Share
BXN	Change in substantial holding		31/05/23	508.15KB	Share
BXN	Notification regarding unquoted securities - BXN		25/05/23	27.97KB	Share
BXN	Ceasing to be a substantial holder X 2		23/05/23	4.07MB	Share
BXN	Becoming a substantial holder		23/05/23	261.87KB	Share
BXN	Becoming a substantial holder		23/05/23	17.74MB	Share
BXN	Final Directors Interest Notice X 2		23/05/23	295.52KB	Share
BXN	Initial Directors Interest Notice X 2		23/05/23	258.84KB	Share
BXN	Cleansing Notice		22/05/23	530.04KB	Share
BXN	Application for quotation of securities - BXN		22/05/23	27.07KB	Share
BXN	Application for quotation of securities - BXN		22/05/23	27.13KB	Share
BXN	Bioxyne Completes Acquisition of Breathe Life Sciences		22/05/23	728.51KB	Share
BXN	Results of Meeting		05/05/23	137.79KB	Share
BXN	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	24/04/23	257.62KB	Share
BXN	Letter to Shareholders re Notice of Meeting		06/04/23	208.63KB	Share
BXN	Notice of Meeting Proxy Form Independent Experts Report		06/04/23	2.7MB	Share
BXN	Bioxyne Executes SPA to Acquire Breathe Life Sciences		20/03/23	236.12KB	Share
BXN	Becoming a substantial holder		27/02/23	134.62KB	Share
BXN	Half Yearly Report and Accounts	PRICE SENSITIVE	23/02/23	748.05KB	Share
BXN	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	27/01/23	266.54KB	Share
BXN	BXN to Acquire Health & Wellness Co Breathe Life Sciences	PRICE SENSITIVE	19/12/22	218.9KB	Share
BXN	New Constitution		30/11/22	468.99KB	Share
BXN	Results of Meeting		28/11/22	158.68KB	Share
BXN	Cleansing Notice		16/11/22	143.06KB	Share
BXN	Application for quotation of securities - BXN		16/11/22	24.59KB	Share
BXN	Proposed issue of securities - BXN		15/11/22	24.54KB	Share
BXN	Notification of cessation of securities - BXN		03/11/22	21.46KB	Share
BXN	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	31/10/22	301.87KB	Share
BXN	Letter to Shareholders on Annual General Meeting Notice		28/10/22	210.07KB	Share
BXN	Notice of Annual General Meeting/Proxy Form		28/10/22	759.64KB	Share
BXN	Cleansing Notice		26/10/22	168.33KB	Share
BXN	Application for quotation of securities - BXN		26/10/22	24.56KB	Share
BXN	Proposed issue of securities - BXN		25/10/22	26.26KB	Share
BXN	Joins Asian Partner & Sells 49% of Direct Selling Business	PRICE SENSITIVE	24/10/22	231.4KB	Share
BXN	AGM Date and Closing Date for Director Nominations		04/10/22	140.67KB	Share
BXN	Appendix 4G and Corporate Governance Statement		30/09/22	413.72KB	Share
BXN	Annual Report to shareholders		30/09/22	1.25MB	Share
BXN	Preliminary Final Report	PRICE SENSITIVE	30/08/22	452.17KB	Share
BXN	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	28/07/22	249.57KB	Share
BXN	Initial Director's Interest Notice		30/06/22	149.94KB	Share
BXN	Final Director's Interest Notice		30/06/22	19.14KB	Share
BXN	Board and Management Changes		08/06/22	177.72KB	Share
BXN	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	28/04/22	246.97KB	Share
BXN	Change of Director's Interest Notice		22/03/22	25.07KB	Share
BXN	Appendix 4D and Interim Report	PRICE SENSITIVE	22/02/22	552.03KB	Share
BXN	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	31/01/22	226.63KB	Share
BXN	Results of Meeting		30/11/21	151.06KB	Share
BXN	Reinstatement to Official Quotation	PRICE SENSITIVE	04/11/21	87.01KB	Share
BXN	Bioxyne Not to Proceed with Proposed Acquisition	PRICE SENSITIVE	04/11/21	143.36KB	Share
BXN	Letter to Shareholders on Annual General Meeting		29/10/21	212.48KB	Share
BXN	Notice of Annual General Meeting/Proxy Form		29/10/21	356.34KB	Share
BXN	Suspension from Quotation	PRICE SENSITIVE	29/10/21	279.03KB	Share
BXN	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	28/10/21	301.61KB	Share
BXN	Trading Halt	PRICE SENSITIVE	27/10/21	205.95KB	Share
BXN	Pause in Trading	PRICE SENSITIVE	27/10/21	113.52KB	Share
BXN	Appendix 4G and Corporate Governance Statement		30/09/21	585.37KB	Share
BXN	Annual Report to shareholders		30/09/21	1.06MB	Share
BXN	Explanatory Note to the 2021 Annual Report	PRICE SENSITIVE	30/09/21	97.05KB	Share
BXN	Preliminary Final Report	PRICE SENSITIVE	31/08/21	601.46KB	Share
BXN	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	22/07/21	427.16KB	Share
BXN	Appendix 4C - quarterly	PRICE SENSITIVE	30/04/21	422.18KB	Share
BXN	Response to ASX Price Query	PRICE SENSITIVE	21/04/21	412.19KB	Share
BXN	Appendix 4D and Half Year Accounts	PRICE SENSITIVE	25/02/21	762.5KB	Share
BXN	Appendix 4C - Quarterly December 2020	PRICE SENSITIVE	29/01/21	427.52KB	Share
BXN	Results of Meeting		26/11/20	134.38KB	Share
BXN	Appendix 4C - quarterly	PRICE SENSITIVE	29/10/20	419.99KB	Share
BXN	Notice of Annual General Meeting/Proxy Form		27/10/20	797.31KB	Share

BXN Quarterly Activities/Appendix 4C Cash Flow Report
30/04/24	PRICE SENSITIVE	985.45KB	Share
BXN Cleansing Notice
22/04/24		675.74KB	Share
BXN Application for quotation of securities - BXN
22/04/24		15.39KB	Share
BXN Proposed issue of securities - BXN
18/04/24		15.15KB	Share
BXN Bioxyne Receives Firm Commitments to Raise $1.45 Million
18/04/24		702.1KB	Share
BXN Bioxyne to Host Webinar on 28 March 2024
25/03/24		667.26KB	Share
BXN Investor Presentation
25/03/24		4.86MB	Share
BXN Notification regarding unquoted securities - BXN
22/03/24		15.56KB	Share
BXN Notification of cessation of securities - BXN
22/03/24		12.69KB	Share
BXN Half Yearly Report and Accounts
29/02/24	PRICE SENSITIVE	2.39MB	Share
BXN BXN Awarded GMP Manufacturing License for Medical Cannabis
05/02/24	PRICE SENSITIVE	762.42KB	Share
BXN Quarterly Report Listing Rule 4.7C.3
05/02/24		661.24KB	Share
BXN Quarterly Activities/Appendix 4C Cash Flow Report
29/01/24	PRICE SENSITIVE	965.25KB	Share
BXN Final Director's Interest Notice
17/11/23		141.7KB	Share
BXN Retirement of Director
17/11/23	PRICE SENSITIVE	564.48KB	Share
BXN Results of Meeting
17/11/23		586.31KB	Share
BXN Annual General Meeting Presentation
17/11/23		7.69MB	Share
BXN Change in substantial holding
06/11/23		156.14KB	Share
BXN Quarterly Activities/Appendix 4C Cash Flow Report
31/10/23	PRICE SENSITIVE	988.5KB	Share
BXN BLS Builds Medicinal Business In Australia
19/10/23		614.62KB	Share
BXN Letter to Shareholders re Annual General Meeting Notice
18/10/23		608.01KB	Share
BXN Notice of Annual General Meeting/Proxy Form
18/10/23		406.33KB	Share
BXN Change of Director's Interest Notice
17/10/23		237.76KB	Share
BXN Change of Director's Interest Notice
09/10/23		170.73KB	Share
BXN AGM Date 2023 and Closing Date for Director Nominations
05/10/23		537.66KB	Share
BXN Annual Report to shareholders
29/09/23		1.74MB	Share
BXN Appendix 4G and Corporate Governance Statement
29/09/23		669.01KB	Share
BXN Preliminary Final Report
31/08/23	PRICE SENSITIVE	603.85KB	Share
BXN Bioxyne Signs Joint Venture with CanXChange
15/08/23		586.37KB	Share
BXN Quarterly Activities/Appendix 4C Cash Flow Report
31/07/23	PRICE SENSITIVE	989.05KB	Share
BXN BLS Extends Amazon Footprint into US and Japan
17/07/23	PRICE SENSITIVE	632.66KB	Share
BXN Bioxyne Launches BLS Clinics - Online Healthcare
13/06/23		628.43KB	Share
BXN Becoming a substantial holder
08/06/23		214.36KB	Share
BXN Becoming a substantial holder
31/05/23		1.22MB	Share
BXN Change in substantial holding
31/05/23		508.15KB	Share
BXN Notification regarding unquoted securities - BXN
25/05/23		27.97KB	Share
BXN Ceasing to be a substantial holder X 2
23/05/23		4.07MB	Share
BXN Becoming a substantial holder
23/05/23		261.87KB	Share
BXN Becoming a substantial holder
23/05/23		17.74MB	Share
BXN Final Directors Interest Notice X 2
23/05/23		295.52KB	Share
BXN Initial Directors Interest Notice X 2
23/05/23		258.84KB	Share
BXN Cleansing Notice
22/05/23		530.04KB	Share
BXN Application for quotation of securities - BXN
22/05/23		27.07KB	Share
BXN Application for quotation of securities - BXN
22/05/23		27.13KB	Share
BXN Bioxyne Completes Acquisition of Breathe Life Sciences
22/05/23		728.51KB	Share
BXN Results of Meeting
05/05/23		137.79KB	Share
BXN Quarterly Activities/Appendix 4C Cash Flow Report
24/04/23	PRICE SENSITIVE	257.62KB	Share
BXN Letter to Shareholders re Notice of Meeting
06/04/23		208.63KB	Share
BXN Notice of Meeting Proxy Form Independent Experts Report
06/04/23		2.7MB	Share
BXN Bioxyne Executes SPA to Acquire Breathe Life Sciences
20/03/23		236.12KB	Share
BXN Becoming a substantial holder
27/02/23		134.62KB	Share
BXN Half Yearly Report and Accounts
23/02/23	PRICE SENSITIVE	748.05KB	Share
BXN Quarterly Activities/Appendix 4C Cash Flow Report
27/01/23	PRICE SENSITIVE	266.54KB	Share
BXN BXN to Acquire Health & Wellness Co Breathe Life Sciences
19/12/22	PRICE SENSITIVE	218.9KB	Share
BXN New Constitution
30/11/22		468.99KB	Share
BXN Results of Meeting
28/11/22		158.68KB	Share
BXN Cleansing Notice
16/11/22		143.06KB	Share
BXN Application for quotation of securities - BXN
16/11/22		24.59KB	Share
BXN Proposed issue of securities - BXN
15/11/22		24.54KB	Share
BXN Notification of cessation of securities - BXN
03/11/22		21.46KB	Share
BXN Quarterly Activities/Appendix 4C Cash Flow Report
31/10/22	PRICE SENSITIVE	301.87KB	Share
BXN Letter to Shareholders on Annual General Meeting Notice
28/10/22		210.07KB	Share
BXN Notice of Annual General Meeting/Proxy Form
28/10/22		759.64KB	Share
BXN Cleansing Notice
26/10/22		168.33KB	Share
BXN Application for quotation of securities - BXN
26/10/22		24.56KB	Share
BXN Proposed issue of securities - BXN
25/10/22		26.26KB	Share
BXN Joins Asian Partner & Sells 49% of Direct Selling Business
24/10/22	PRICE SENSITIVE	231.4KB	Share
BXN AGM Date and Closing Date for Director Nominations
04/10/22		140.67KB	Share
BXN Appendix 4G and Corporate Governance Statement
30/09/22		413.72KB	Share
BXN Annual Report to shareholders
30/09/22		1.25MB	Share
BXN Preliminary Final Report
30/08/22	PRICE SENSITIVE	452.17KB	Share
BXN Quarterly Activities/Appendix 4C Cash Flow Report
28/07/22	PRICE SENSITIVE	249.57KB	Share
BXN Initial Director's Interest Notice
30/06/22		149.94KB	Share
BXN Final Director's Interest Notice
30/06/22		19.14KB	Share
BXN Board and Management Changes
08/06/22		177.72KB	Share
BXN Quarterly Activities/Appendix 4C Cash Flow Report
28/04/22	PRICE SENSITIVE	246.97KB	Share
BXN Change of Director's Interest Notice
22/03/22		25.07KB	Share
BXN Appendix 4D and Interim Report
22/02/22	PRICE SENSITIVE	552.03KB	Share
BXN Quarterly Activities/Appendix 4C Cash Flow Report
31/01/22	PRICE SENSITIVE	226.63KB	Share
BXN Results of Meeting
30/11/21		151.06KB	Share
BXN Reinstatement to Official Quotation
04/11/21	PRICE SENSITIVE	87.01KB	Share
BXN Bioxyne Not to Proceed with Proposed Acquisition
04/11/21	PRICE SENSITIVE	143.36KB	Share
BXN Letter to Shareholders on Annual General Meeting
29/10/21		212.48KB	Share
BXN Notice of Annual General Meeting/Proxy Form
29/10/21		356.34KB	Share
BXN Suspension from Quotation
29/10/21	PRICE SENSITIVE	279.03KB	Share
BXN Quarterly Activities/Appendix 4C Cash Flow Report
28/10/21	PRICE SENSITIVE	301.61KB	Share
BXN Trading Halt
27/10/21	PRICE SENSITIVE	205.95KB	Share
BXN Pause in Trading
27/10/21	PRICE SENSITIVE	113.52KB	Share
BXN Appendix 4G and Corporate Governance Statement
30/09/21		585.37KB	Share
BXN Annual Report to shareholders
30/09/21		1.06MB	Share
BXN Explanatory Note to the 2021 Annual Report
30/09/21	PRICE SENSITIVE	97.05KB	Share
BXN Preliminary Final Report
31/08/21	PRICE SENSITIVE	601.46KB	Share
BXN Quarterly Activities/Appendix 4C Cash Flow Report
22/07/21	PRICE SENSITIVE	427.16KB	Share
BXN Appendix 4C - quarterly
30/04/21	PRICE SENSITIVE	422.18KB	Share
BXN Response to ASX Price Query
21/04/21	PRICE SENSITIVE	412.19KB	Share
BXN Appendix 4D and Half Year Accounts
25/02/21	PRICE SENSITIVE	762.5KB	Share
BXN Appendix 4C - Quarterly December 2020
29/01/21	PRICE SENSITIVE	427.52KB	Share
BXN Results of Meeting
26/11/20		134.38KB	Share
BXN Appendix 4C - quarterly
29/10/20	PRICE SENSITIVE	419.99KB	Share
BXN Notice of Annual General Meeting/Proxy Form
27/10/20		797.31KB	Share

REFRESH

1 2 3 4

(20min delay)
Last 0.7¢		Change 0.001(16.7%)		Mkt cap ! $14.32M

Open	High	Low	Value	Volume
0.7¢	0.7¢	0.7¢	$1.161K	165.8K

Buyers (Bids)

No.	Vol.	Price($)
5	4925733	0.6¢

Sellers (Offers)

Price($)	Vol.	No.
0.7¢	1922982	5

View Market Depth

No.	Vol.	Price($)
5	4925733	0.006
10	2807636	0.005
4	1277000	0.004
3	1600000	0.003
4	1955000	0.002

Price($)	Vol.	No.
0.007	1922982	5
0.008	2615897	4
0.009	430000	2
0.010	520333	3
0.011	757969	2

Last trade - 16.10pm 02/05/2024 (20 minute delay)


Last 0.7¢		Change 0.001 ( 16.7 %)
Open	High	Low	Volume
0.7¢	0.7¢	0.7¢	600000
Last updated 14.47pm 02/05/2024 ?

BXN (ASX) Chart

BIOXYNE LIMITED - Announcements

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories